Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial

作者：Robert P. Frantz, Vallerie V. McLaughlin, Sandeep Sahay, Pilar Escribano Subías, Ronald Zolty, Raymond L. Benza, Richard N. Channick, Kelly Chin, Anna R. Hemnes, Luke Howard, Olivier Sitbon, Jean‐Luc Vachiéry, Roham T. Zamanian, Matt Cravets, Robert F. Roscigno, David Mottola, Robin Osterhout, Jean‐Marie Bruey, Erin Elman, Cindy‐ann Tompkins, Ed Parsley, Richard Aranda, Lawrence S. Zisman, Hossein-Ardeschir Ghofrani, Yochai Adir, T. Baillie, David Baratz, Charles Burger, Murali M. Chakinala, Jose Ales Martinez, Marion Delcroix, Nathan Dwyer, Jean Elwing, Micah R. Fisher, Verónica Franco, Ekkehard Grünig, Kristin B. Highland, Nicholas S. Hill, Naushad Hirani, Marius M. Hoeper, Pavel Jansa, Anne Keogh, J.F. Kingrey, Manuel López‐Meseguer, John W. McConnell, Sanjay Mehta, Lana Melendres‐Groves, Christian Opitz, Joanna Pepke‐Żaba, Priya Pillutla, Franck Rahaghi, Amresh Raina, Yael Raviv, Jeffrey C. Robinson, John Ryan, Jeffrey S. Sager, Shelley Shapiro, Marc A. Simon, Kerri Smith, I. Sobol, Namita Sood, Leslie Spikes, Stefan Stadler, Wendy B.C. Stevens, Roxana Sulica, R. James White · 发表于：The Lancet Respiratory Medicine · 年份：2024 · DOI：10.1016/s2213-2600(24)00072-9 · 被引用次数：67 · 研究领域：Pulmonary Hypertension Research and Treatments、Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis、Chronic Obstructive Pulmonary Disease (COPD) Research